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Abstract
Objectives: Assessment of a pancreaticoduodenectomy specimen by pathologists requires specialized
knowledge of anatomy. Standardized assessment, description and documentation of the retroperitoneal
margin are crucial for the accurate interpretation of studies evaluating adjuvant therapy for pancreatic
cancer patients.
Methods: Twenty-five patients who underwent a pancreaticoduodenectomy for pancreatic adenocarci-
nomas had their pathological specimens examined prospectively, using an anatomical-based mapping
approach. All margins, including the bile duct, pancreatic neck, superior mesenteric artery, superior
mesenteric vein and posterior surface of the uncinate process, were microscopically examined in their
entirety. The assessment of an R1 margin in terms of distance was assessed in two ways: first defining
it as a tumour at the margin or secondary as tumour within 1 mm (1 mm rule).
Results: If the existing College of American Pathologists recommendations were applied (assessing only
the bile duct, pancreatic neck and superior mesenteric artery margins), a R1 status would be achieved in
only 9 of 25 patients. Extending the examination by assessment and reporting of the entire retroperitoneal
resection margin, including the Superior Mesenteric Vein margin and the Posterior surface of the uncinate
process margin, increased the number of patients with a R1 resection to 14 out of 25. Applying the 1-mm
rule further increased the number of patient with a R1 resection to 20 of 25 patients.
Conclusions: The above findings illustrate that different approaches to the assessment and reporting
of the retroperitoneal margin can change the results and adversely affect the final statistics used in
pancreatic cancer studies and clinical trials.
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Introduction
A pancreaticoduodenectomy with adjuvant chemotherapy
remains the only hope of a cure for localized cancers of the pan-
creatic head and uncinate process (UP).1,2 Pathological assessment
of the pancreaticoduodenectomy (PD) specimen requires special-
ized knowledge of anatomy. Standardization of surgical and
pathological techniques is crucial to the interpretation of the
studies needed to plan adjuvant therapy for pancreatic cancer.3
However, consensus guidelines for the handling and reporting of a
PD specimen are distinctly lacking.4–9 A major explanation lies in
the inconsistent assessment, description and documentation of
the posterior, retroperitoneal tissue/circumferential surfaces.3,9
To highlight the lack of standardization, Katz et al.3 reviewed
79 pathology reports from patients included in the multicentre
ACOSOG Z5031 trial and found documentation of the ‘uncinate
process margin’, ‘retroperitoneal margin’, ‘superior mesenteric
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artery (SMA) margin’, ‘radial margin’, ‘deep margin’ and ‘posterior
margin’; all referring to margins in the retroperitoneum. Even the
American Joint Committee on Cancer (AJCC)10 and the College
of American Pathologists (CAP) guidelines11 appear to disagree
on the designation and relative importance of tissue in this
region.3 CAP11 emphasized the oncological significance of the
non-peritonealized surface of the uncinate margin and posterior
retroperitoneal surface of the pancreas. While the definition of
the former is relatively clear, the definition of the latter lacks
detailed guidance3,7,9 and as a result, in day-to-day practice, there
is inconsistency and ambiguity in the evaluation and reporting
of the pancreatic margin.6,9,10 Recently, the AJCC Cancer Staging
Manual10 recommended using the term superior mesenteric
artery (SMA) margin (SMAM) instead of the retroperitoneal
or uncinate margin.
The approach to analyse the PD margins is another challenge
(Table 1). The oldest and the most common approach in North
America4 requires assessment of the bile duct resection (transec-
tion) margin (BDM), distal pancreatic (pancreatic neck) resection
(transection) margin (PNM) and the SMAM. However, there is no
consensus about pathological examination of the rest (excluding
SMAM) of the posterior (retroperitoneal) surface of the PD.
Staley et al.,4 Luttges et al.,5 as well as CAP11 recommend sampling
of the tumour at its closest point to the posterior surface, empha-
sizing the importance of the assessment of mainly SMAM (CAP
uses the term uncinate margin). Verbecke et al.7,12 offered a
through discussion of the concept of the circumferential margin
of the PD, which is divided into three components: the anterior,
posterior and medial (facing superior mesenteric vessels).8,12 In
2009, Verbeke and Menon redefined resection margin status in
pancreatic carcinoma13 by dividing the circumferential resection
margin into the anterior surface, SMV surface, SMA surface and
posterior surface, which was accepted by the 2010 edition of The
Royal College of Pathologists of United Kingdom.14
Similar, an anatomical-based approach was described by
Khalifa et al. in 2009.9 The entire posterior retroperitoneal surface
of the head of the pancreas was divided (mapping) into the unci-
nate margin (facing to SMA), the groove or vascular bed (facing
to SMV) and the posterior surface of the UP.
The goals of this study were to (i) present the results of the
prospective evaluation of the pancreatic margins, based on ana-
tomic landmarks and (ii) demonstrate how different approaches
to reporting of pancreatic margins can affect R1 status, synoptic
reporting and statistical data.
Material and methods
From July 2006 to March 2011, 62 consecutive patients underwent
PD at the Department of Surgery, Eastern Health, St. John’s,
Newfoundland, Canada. In all 62 patients, mapping of the entire
retroperitoneal margin (RPM) (see Figs 1,2) was performed pro-
spectively according to an anatomical-based mapping protocol
described below. Of these 62 patients, 28 had primary pancreatic
adenocarcinoma with a macroscopically free margin (R0 or R1
resection). An important part was the submission of the entire
RPM in total. However, in 3 of the 28 patients, RPM was not
examined in total microscopically, and, therefore these patients
were excluded from the study. Twenty-five patients were included
in this study.
Standardized, anatomical-based mapping protocol for
examining PD specimens
The specimen was assessed fresh by the same experienced hepato-
pancreato-biliary pathologist (VM) and when necessary, it was
Table 1 Comparison of margins reported in pancreaticoduodenectomy specimen






SMAM/uncinate (retroperitoneal) margin + + - +
SMVM - + - +
Mediala - - + -
Posterior - + + +
PNM + + + +
BDM + + + +
Anterior - + + +/-c
Otherb + - - -
+ margin reported.
- margin not reported.
a‘Medial circumferential resection margin, the part of the surface of the pancreatic head that faces the superior mesenteric vessels’.12
bThe following description is available in CAP Cancer protocols. Pancreas (exocrine), 2012:11 ‘deep retroperitoneal posterior surface of the
pancreas . . . recommend inking the posterior surface of the pancreas and submission of sections through the tumour at its closest approach to this
surface’.
cIn the author's opinion, the anterior margin present in a pylorus-preserving pancreaticoduodenectomy and absent in a standard Whipple procedure.
BDM, Bile duct margin; CAP, College of American Pathologists; PNM, Pancreatic neck margin; RCPUK, The Royal College of Pathologists of United
Kingdom; SMAM, Superior mesenteric artery margin; SMVM, Superior mesenteric vein margin.
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reviewed with the surgeon. The retroperitoneal surface of the
specimen was divided into the following components (margins):
the SMAM, SMVM and posterior surface of the uncinate process
margin (PUPM) and, if an extended PD was performed, the
medial aspect (posterior surface along the neck of the pancreas).
Each margin was inked with a different colour (mapping) includ-
ing the corresponding superior and inferior aspect for each
margin (Figs 1,2). SMAM was carefully evaluated before inking
and a comment in the gross description was made if there was
exposed pancreatic tissue (incomplete skeletonization of the
SMA) at the margin. This could result from cutting through the
tip of the UP facing the SMA and, as a result, pancreatic tissue
adjacent to the SMA may be left behind in the patient. When
non-exposed pancreatic tissue was found, this implied that it was
more likely that complete skeletonization of the SMA took place.
The stomach, duodenum and common bile duct were open and
assessed in situ. After fixation in formalin for at least 24 h, gastric,
duodenal, pancreatic neck margin (PNM) and bile duct margin
(BDM) were submitted en face. BDM and PNM submitted in
total. The entire RPM, divided into the SMAM, SMVM and
PUPM, was shaved (0.5 cm thick rim of tissue), kept oriented and
submitted in total for microscopic examination, serially
sectioned, perpendicular to RPM, into maximum 3–5 mm thick
slices, from the superior to inferior, with clear identification of
orientation and identification of the superior, medial and inferior
aspect. Contrary to all existing/previous protocols, the entire
RPM, including the SMAM, SMVM and PUPM, was submitted in
total for microscopic examination.
The ampulla of the Vater was submitted in total for microscopic
examination, en block with underlying pancreas, sectioned longi-
tudinally along the long axis of the CBD. This approach showing
the relationship between CBD, main pancreatic duct, pancreas
and duodenal wall in an aim to help differentiate carcinoma origi-
nating from ampulla, distal CBD and periampullary pancreatic
carcinoma.
Table 1 shows the difference in margins reporting by different
jurisdictions and author’s approach.
Distance of the tumour from the closest margin was measured
microscopically. A microscopically measured 1-mm tumour-free
zone was used as the cutoff. A presence of the tumour at the
margin (0 mm rule) as is recommended by CAP or at 1 mm or less
(1 mm rule) was documented for the purpose of this study.
Results
Of the 25 patients (12 women and 13 men, median age 65.5 years;
range 46–76), 24 patients underwent a standard PD (in 1 cases
standard PD was transformed in total pancreatectomy) and 1
patient underwent a pylorus-preserving PD. There were 4 patients
with vascular resection. Frozen sections from the BDM and pan-
creatic neck RM were performed upon macroscopic suspicion of
tumour involvement in 15 and 18 cases, respectively. None of the
patients died within 30 days of surgery.
The results of R1 status by definition are shown in Table 2.
The most frequently involved margins were SMAM and
SMVM. Based on 1-mm rule SMVM was involved in 18 out of 20
Figure 1 Pancreaticoduodenectomy (standard) specimen. Posterior
view (mapping using different colours/dyes). Green, distal pancre-
atic resection margin; Red, superior mesenteric vein (vascular
groove) dissection margin; Yellow, superior mesenteric vein (SMV)
adhered to the posterior lateral aspect of the SMV dissection margin
(the probe inserted in the lumen of the SMV); Black, SMA resection
margin; Blue, posterior surface of the uncinate process dissection
margin
Figure 2 Pancreaticoduodenectomy (standard) specimen (the same
case as previous Fig. 1, view from the closer distance). Posterior
view (mapping using different colours/dyes). Green, distal pancre-
atic resection margin; Red, superior mesenteric vein (vascular
groove) dissection margin; Yellow, superior mesenteric vein (SMV)
adhered to the posterior lateral aspect of the SMV dissection margin
(the probe inserted in the lumen of the SMV); Black, SMA resection
margin; Blue, posterior surface of the uncinate process dissection
margin
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patients with R1 resection and SMAM in 14 out of 20 patients
with an R1 margin. More details are shown in Table 3.
The number of margins involved based on definition is shown
in Table 4.
Discussion
PNM and/or BDM are usually assessed intra-operatively by frozen
sections and it is unusual to have positive margins on permanent
sections unless a frozen section examination was not done. The
main focus of this study was a RPM which is the entire posterior,
deep surface of the pancreas. Assessment and reporting of the
RPM remain controversial and performed differently.3 CAP
emphasize the importance of SMAM and recommends reporting
involvement of the rest of deep retroperitoneal posterior surface
of the head of the pancreas without attempting to map and report
separately involvement of SMVM and PUPM.11
The aim of this study was to investigate how assessment of
the RPM using an anatomical-based mapping approach of sam-
pling9,15,16 can affect final reporting and hence the number of
patients with an R1 resection. To achieve this, the entire RPM,
divided into the SMAM, SMVM and PUPM, was assessed
microscopically in total, which is currently followed in only few
centres.17–19 The existing literature is predominantly based on
the assessment of SMAM only20 or with ‘submission of section
through the tumour at its closest point to deep retroperitoneal
posterior surface’,11 which is often called the ‘peripancreatic mar-
gin’.21,22 Following this trend and applying the 0-mm rule, the
number of patients with a R1 resection in the current series would
have been 9 out of 25, these figures correlates with the existing
literature (16%-36%) based on a large series where only assess-
ment of the SMAM20 or peripancreatic tissue has been per-
formed.21,22 However, extending the examination by assessment
and reporting of the entire RPM while still adopting the 0-mm
rule, would increase the number of patients with R1 resection to
14 out of 25 patients.
There is lack of consensus for the definition of margin involve-
ment. It ranges from 0 mm definition in North America11 to 1 mm
in Europe12,23 and Japan.24 Applying the 1-mm rule, the number of
patients with R1 resection in the current series increased from 14
to 20 patients. The result is very similar to the R1 rate reported by
Verbeke et al.7 and Esposito et al.8 and correlates with the high
(67% to 86%) local recurrence rate.7,8,25 Recent discussions related
to the work of Hernandez et al.,22 who showed that survival after
PD is not improved by extending resections to achieve negative
margins, indicated that controversies still exist and a 1.5-mm
clearance might be needed to obtain a long-term survival
benefit.26
It is a common belief that SMAM is the most commonly
involved margin,20,25 but often it is based on the protocols exam-
ining only the BDM, PNM and SMAM.20 In the current series, the
most frequently involved margins were SMVM, SMAM and less
often the PUPM. Interestingly, the SMAM was involved as often as
the SMVM (9 patients), but based on the 1-mm rule, the SMVM
was involved in 18 out of 20 patients with an R1 resection and
SMAM in 14 out of 20 patients with an R1 resection. The SMAM,
SMVM or both were involved in 13 out of 14 patients with an R1
resection and based on the 1-mm rule in 15 out of the 20 patients
with an R1 resection. The PUPM was involved less often and it was
never a single source of R1 status. It is related to the nature of the
anatomy, surgery and criteria for the selection of patients. Very
often owing to the close anatomical relationship of the retroperi-
Table 2 Margin involvement
Margin Based on CAP
approach
Based on author's approach
(0 mm rule) (1 mm rule)
SMAM 9a 9a 14
SMVM - 9 18
PUPM - 1 5
PNM 1 1 1
BDM 1 1 1
Total R1 9b 14b 20b
aIn one patient, the SMAM was involved by metastatic carcinoma in a
lymph node and this patient was not included as it was considered as
locoregional metastasis.
bOwing to multifocality of resection margin involvement within the same
specimen in some patients, the total number of involved margin exceeds
the total number of patients with an R1 margin.
BDM, Bile duct margin; CAP, College of American Pathologists;
PNM, Pancreatic neck margin; PUPM, Posterior surface of the uncinate
process margin; SMAM, Superior mesenteric artery margin; SMVM,
Superior mesenteric vein margin.
Table 3 The number of patients with retroperitoneal margin involve-
ment by definition
Based on definition
by CAP (0 mm rule)
Based on
1 mm rule
SMAM only 5 2
SMVM only 5 5
SMAM and SMVM 3 8
TOTAL (R1) cases 13 15
SMAM  SMVM & PUPM 1 5
PUPM only - -
Total (R1) 14 20
CAP, College of American Pathologists; PUPM, Posterior surface of the
uncinate process margin; SMAM, Superior mesenteric artery margin;
SMVM, Superior mesenteric vein margin.




Based on definition by






Total (R1) 14 20
CAP, College of American Pathologists.
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toneal surface to the SMA and SMV it is impossible or difficult to
reach a negative margin and many surgeons are still hesitant to
proceed with en block resection, especially if it was not planned in
advance. The situation is different along the posterior surface of
the uncinate process, which is separated by fat from the underly-
ing structures such as the inferior vena cava and it is much easier
to obtain a clear margin.
Two or more margins were involved only in 4 out of 14 patients
with a R1 resection. However, using the 1-mm rule would increase
the number patients with two or more positive margins to 13 out
of 20 patients. This finding indicates that careful examination of
the entire RPM is important to accurately identify patients with an
R1 resection. Clearly this has important implications for clinical
trials as it could alter the R1 status dramatically.
Coexisting fibrosis might be a misleading feature during gross
assessment and selection of sections. At the same time, invasion
of the peripancreatic adipose tissue by single malignant glands
cannot be grossly identifiable (Fig. 3) therefore highlighting the
importance of complete assessment of the RPM.
The described approach can reasonably be adopted in special-
ized centres that developed enough expertise and confidence in
gross assessment. As it is now widely accepted that the SMAM can
be identified, selection, recognition and inking of other retroperi-
toneal zones (surfaces) should not be too difficult. It is the
author’s view that it is much easier to recognize the SMAM in
patients with incomplete skeletonization of the SMA than in the
patients with complete skeletonization. Surgeons can also be
encouraged to mark the SMAM with a suture during surgery. In
the author’s experience, borderline resectable patients where this
particular issue is important, the SMAM is easier to identify. The
critical assessment of this margin, particularly in the intra-
operative setting, has already been described in detail.27
In conclusion, this study illustrates that different approaches to
the assessment and reporting of the RPM can completely change
the frequency of R1 status within a series and affect the final
understanding in related clinical trials. Involvement of the SMVM
and SMAM should be included in standard protocols. It is impor-
tant for quality assurance and for providing reliable feedback.
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